Diagnostic Accuracy of FIB-4 Index and FIB-3 Index for Advanced Fibrosis in Chronic Liver Disease and Age-Specific Thresholds
<b>Background and Aims:</b> Given the high prevalence of chronic liver diseases, non-invasive assessment of liver fibrosis is critical for screening and management of these conditions. While the FIB-4 index is widely used, its age-dependent nature may reduce specificity in older adults. The FIB-3 index, which excludes age, has been proposed as an alternative. This study aimed to compare the diagnostic performance of FIB-3 and FIB-4 for detecting advanced fibrosis across age groups using magnetic resonance elastography (MRE) as the reference standard. <b>Methods:</b> We retrospectively analyzed 3424 patients aged ≥30 years with chronic liver disease who underwent MRE. Advanced fibrosis was defined as liver stiffness ≥ 3.62 kPa. The cutoff values and diagnostic performance of the FIB-4 and FIB-3 indices for advanced fibrosis were evaluated within subgroups stratified by age quartiles (Q1-Q4), and the areas under the ROC curves (AUROCs) were compared using DeLong's test. <b>Results:</b> Both FIB-3 and FIB-4 indices demonstrated comparable diagnostic accuracy for advanced fibrosis (AUROC 0.82 (95% CI: 0.81-0.83) for both; <i>p</i> = 0.70). In age-stratified analysis, the cutoff values for the FIB-4 index increased with increasing age (Q1: 1.72, Q2: 2.90, Q3: 3.66, Q4: 4.20), reflecting its age-dependent formula. In contrast, the FIB-3 index exhibited relatively minor variation in cutoff values across quartiles (Q1: 2.32, Q2: 3.52, Q3: 3.74, Q4: 3.14). <b>Conclusions:</b> FIB-3 index offers similar diagnostic accuracy to FIB-4 index while demonstrating more consistent performance across age groups. These findings provide evidence that FIB-3 index may be a useful alternative, particularly in older populations where FIB-4 index interpretation may be confounded by age.
Authors
- Hitomi Takada (ORCID: https://orcid.org/0000-0003-2101-0454)
- Kenta Takaura (ORCID: https://orcid.org/0000-0003-2644-8084)
- Yudai Yamazaki (ORCID: https://orcid.org/0000-0002-4714-0823)
- Masayuki Kurosaki
- Yuki Tanaka (ORCID: https://orcid.org/0000-0002-0115-500X)
- Kaoru Tsuchiya (ORCID: https://orcid.org/0000-0003-0436-5915)
- Nobuharu Tamaki
- Yutaka Yasui (ORCID: https://orcid.org/0000-0002-6117-4990)
- Ryohei Kobayashi (ORCID: https://orcid.org/0000-0001-8364-5354)
- Yasuo Kasano
- Shohei Kimura (ORCID: https://orcid.org/0009-0004-2162-7176)
- Masayuki Taguchi
- Namiki Izumi (ORCID: https://orcid.org/0000-0002-0055-8229)
- Yasuyuki Komiyama
- Naoki Uchihara
- Chiaki Maeyashiki (ORCID: https://orcid.org/0000-0003-3026-7438)
- Shohei Tanaka
- Hiroyuki Nakanishi
- Mayu Higuchi
- T. Shima
- Junko Yagita
- Risa Seike
Institutions
- Musashino Red Cross Hospital (JP)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-11-28
- DOI
- https://doi.org/10.3390/jcm14238473
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35